Metabolic Waypoints During T Cell Differentiation

Overview

Journal Nat Immunol

Date 2024 Jan 18

PMID 38238609

Authors

Drew Wilfahrt

Greg M Delgoffe

Affiliations

Soon will be listed here.

Abstract

This Review explores the interplay between T cell activation and cell metabolism and highlights how metabolites serve two pivotal functions in shaping the immune response. Traditionally, T cell activation has been characterized by T cell antigen receptor-major histocompatibility complex interaction (signal 1), co-stimulation (signal 2) and cytokine signaling (signal 3). However, recent research has unveiled the critical role of metabolites in this process. Firstly, metabolites act as signal propagators that aid in the transmission of core activation signals, such as specific lipid species that are crucial at the immune synapse. Secondly, metabolites also function as unique signals that influence immune differentiation pathways, such as amino acid-induced mTORC1 signaling. Metabolites also play a substantial role in epigenetic remodeling, by directly modifying histones, altering gene expression and influencing T cell behavior. This Review discusses how T cells integrate nutrient sensing with activating stimuli to shape their differentiation and sensitivity to metabolites. We underscore the integration of immunological and metabolic inputs in T cell function and suggest that metabolite availability is a fundamental determinant of adaptive immune responses.

Citing Articles

The clinical significance of T-cell regulation in hypertension treatment.

Fu M, Lv M, Guo J, Mei A, Qian H, Yang H Front Immunol. 2025; 16:1550206.

PMID: 40079010 PMC: 11897580. DOI: 10.3389/fimmu.2025.1550206.

Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia.

Jacobs C, Peters F, Camerini E, Cretenet G, Rietveld J, Schomakers B Cell Mol Immunol. 2025; .

PMID: 40033083 DOI: 10.1038/s41423-025-01262-1.

The absolute number of circulating Treg cells is reduced in difficult-to-treat RA patients and is ameliorated by low-dose IL-2.

Yan H, Zi X, Yan H, Zhang X, Bai J, Gao C Front Immunol. 2025; 16:1522893.

PMID: 39981233 PMC: 11839615. DOI: 10.3389/fimmu.2025.1522893.

T cell metabolism in kidney immune homeostasis.

Liu Z, Dai B, Bao J, Pan Y Front Immunol. 2024; 15:1498808.

PMID: 39737193 PMC: 11684269. DOI: 10.3389/fimmu.2024.1498808.

Engineering bacteria for cancer immunotherapy by inhibiting IDO activity and reprogramming CD8+ T cell response.

Wang H, Xu F, Yao C, Dai H, Xu J, Wu B Proc Natl Acad Sci U S A. 2024; 121(52):e2412070121.

PMID: 39693352 PMC: 11670085. DOI: 10.1073/pnas.2412070121.

References

Smith-Garvin J, Koretzky G, Jordan M . T cell activation. Annu Rev Immunol. 2009; 27:591-619. PMC: 2740335. DOI: 10.1146/annurev.immunol.021908.132706. View

Pathan-Chhatbar S, Drechsler C, Richter K, Morath A, Wu W, Ouyang B . Direct Regulation of the T Cell Antigen Receptor's Activity by Cholesterol. Front Cell Dev Biol. 2021; 8:615996. PMC: 7820176. DOI: 10.3389/fcell.2020.615996. View

Wu W, Shi X, Xu C . Regulation of T cell signalling by membrane lipids. Nat Rev Immunol. 2016; 16(11):690-701. DOI: 10.1038/nri.2016.103. View

He H, Lellouch A, Marguet D . Lipid rafts and the initiation of T cell receptor signaling. Semin Immunol. 2004; 17(1):23-33. DOI: 10.1016/j.smim.2004.09.001. View

Jury E, Flores-Borja F, Kabouridis P . Lipid rafts in T cell signalling and disease. Semin Cell Dev Biol. 2007; 18(5):608-15. PMC: 2596300. DOI: 10.1016/j.semcdb.2007.08.002. View

Kabouridis P . Lipid rafts in T cell receptor signalling . Mol Membr Biol. 2006; 23(1):49-57. PMC: 2596298. DOI: 10.1080/09687860500453673. View

Chen Y, Zhu Y, Li X, Gao W, Zhen Z, Dong D . Cholesterol inhibits TCR signaling by directly restricting TCR-CD3 core tunnel motility. Mol Cell. 2022; 82(7):1278-1287.e5. DOI: 10.1016/j.molcel.2022.02.017. View

Bensinger S, Bradley M, Joseph S, Zelcer N, Janssen E, Hausner M . LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell. 2008; 134(1):97-111. PMC: 2626438. DOI: 10.1016/j.cell.2008.04.052. View

Wilfahrt D, Philips R, Lama J, Kizerwetter M, Shapiro M, McCue S . Histone deacetylase 3 represses cholesterol efflux during CD4 T-cell activation. Elife. 2021; 10. PMC: 8639145. DOI: 10.7554/eLife.70978. View

10.

Lu W, Helou Y, Shrinivas K, Liou J, Au-Yeung B, Weiss A . The phosphatidylinositol-transfer protein Nir3 promotes PI(4,5)P replenishment in response to TCR signaling during T cell development and survival. Nat Immunol. 2022; 24(1):136-147. PMC: 9810531. DOI: 10.1038/s41590-022-01372-2. View

11.

Edwards-Hicks J, Apostolova P, Buescher J, Maib H, Stanczak M, Corrado M . Phosphoinositide acyl chain saturation drives CD8 effector T cell signaling and function. Nat Immunol. 2023; 24(3):516-530. PMC: 10908374. DOI: 10.1038/s41590-023-01419-y. View

12.

Kremer K, Buser A, Thumkeo D, Narumiya S, Jacobelli J, Pelanda R . LPA suppresses T cell function by altering the cytoskeleton and disrupting immune synapse formation. Proc Natl Acad Sci U S A. 2022; 119(15):e2118816119. PMC: 9169816. DOI: 10.1073/pnas.2118816119. View

13.

Mathew D, Kremer K, Strauch P, Tigyi G, Pelanda R, Torres R . LPA Is an Inhibitory Receptor That Suppresses CD8 T-Cell Cytotoxic Function via Disruption of Early TCR Signaling. Front Immunol. 2019; 10:1159. PMC: 6558414. DOI: 10.3389/fimmu.2019.01159. View

14.

Castellano F, Molinier-Frenkel V . Control of T-Cell Activation and Signaling by Amino-Acid Catabolizing Enzymes. Front Cell Dev Biol. 2021; 8:613416. PMC: 7773816. DOI: 10.3389/fcell.2020.613416. View

15.

Wu J, Li G, Li L, Li D, Dong Z, Jiang P . Asparagine enhances LCK signalling to potentiate CD8 T-cell activation and anti-tumour responses. Nat Cell Biol. 2021; 23(1):75-86. DOI: 10.1038/s41556-020-00615-4. View

16.

Hope H, Brownlie R, Fife C, Steele L, Lorger M, Salmond R . Coordination of asparagine uptake and asparagine synthetase expression modulates CD8+ T cell activation. JCI Insight. 2021; 6(9). PMC: 8262305. DOI: 10.1172/jci.insight.137761. View

17.

Geiger R, Rieckmann J, Wolf T, Basso C, Feng Y, Fuhrer T . L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity. Cell. 2016; 167(3):829-842.e13. PMC: 5075284. DOI: 10.1016/j.cell.2016.09.031. View

18.

Carr E, Kelman A, Wu G, Gopaul R, Senkevitch E, Aghvanyan A . Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation. J Immunol. 2010; 185(2):1037-44. PMC: 2897897. DOI: 10.4049/jimmunol.0903586. View

19.

Wang R, Dillon C, Shi L, Milasta S, Carter R, Finkelstein D . The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity. 2011; 35(6):871-82. PMC: 3248798. DOI: 10.1016/j.immuni.2011.09.021. View

20.

Johnson M, Wolf M, Madden M, Andrejeva G, Sugiura A, Contreras D . Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism. Cell. 2018; 175(7):1780-1795.e19. PMC: 6361668. DOI: 10.1016/j.cell.2018.10.001. View